GlassScriptPhysician profile
John T Gallen
NPI 1114993656
$3,067.08
in general payments reported to CMS, 2019-2025
26 companies · $456 in 2025
The $456 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,005 · 2020: $986 · 2021: $169 · 2022: $267 · 2023: $90.53 · 2024: $93.30 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $565.23 | 2019-2025 | Evenity, Repatha, Tepezza |
| Novo Nordisk INC | $510.23 | 2019-2025 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $265.68 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $262.75 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $235.24 | 2019-2020 | |
| Dexcom, INC. | $189.02 | 2019-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $167.88 | 2019-2022 | |
| Tandem Diabetes Care, INC. | $127.58 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Merck Sharp & Dohme LLC | $119.68 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.87 | 2019-2025 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $60.68 | 2019 | |
| Recordati_rare_diseases_inc. | $57.75 | 2020 | |
| Horizon Therapeutics Plc | $49.58 | 2021-2022 | |
| Amarin Pharma, INC. | $46.69 | 2020 | |
| Medtronic, INC. | $42.44 | 2024-2025 | Minimed 780g |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beta Bionics, INC. | $37.50 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Esperion Therapeutics, INC. | $36.40 | 2020 | |
| Radius Health, INC. | $34.11 | 2019-2020 | |
| Pfizer INC. | $30.07 | 2019 | |
| Mindray Ds USA, INC. | $26.11 | 2024 | Te7 Max, Te X |
| Medtronic Minimed, INC. | $25.92 | 2019-2020 | |
| Abbott Laboratories | $22.23 | 2022 | |
| Alexion Pharmaceuticals, INC. | $20.37 | 2025 | Strensiq |
| Shire North American Group INC | $18.70 | 2019 | |
| Sequel Med Tech, LLC | $17.79 | 2025 | Twiist |
| Corcept Therapeutics | $12.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gallen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.